NO20023697L - Cykliske heksapeptidderivater - Google Patents

Cykliske heksapeptidderivater

Info

Publication number
NO20023697L
NO20023697L NO20023697A NO20023697A NO20023697L NO 20023697 L NO20023697 L NO 20023697L NO 20023697 A NO20023697 A NO 20023697A NO 20023697 A NO20023697 A NO 20023697A NO 20023697 L NO20023697 L NO 20023697L
Authority
NO
Norway
Prior art keywords
cyclic hexapeptide
hexapeptide derivatives
derivatives
cyclic
hexapeptide
Prior art date
Application number
NO20023697A
Other languages
English (en)
Other versions
NO20023697D0 (no
Inventor
Ayako Toda
Takahiro Matsuya
Hiroaki Mizuno
Hiroshi Matsuda
Kenji Murano
David Barrett
Takashi Ogino
Keiji Matsuda
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ5752A external-priority patent/AUPQ575200A0/en
Priority claimed from AUPQ9552A external-priority patent/AUPQ955200A0/en
Priority claimed from AUPR2344A external-priority patent/AUPR234400A0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO20023697D0 publication Critical patent/NO20023697D0/no
Publication of NO20023697L publication Critical patent/NO20023697L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20023697A 2000-02-21 2002-08-06 Cykliske heksapeptidderivater NO20023697L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPQ5752A AUPQ575200A0 (en) 2000-02-21 2000-02-21 New compound
AUPQ9552A AUPQ955200A0 (en) 2000-08-21 2000-08-21 New compound
AUPR2344A AUPR234400A0 (en) 2000-12-28 2000-12-28 New compound
PCT/JP2001/001204 WO2001060846A1 (en) 2000-02-21 2001-02-20 Cyclic hexapeptide derivatives

Publications (2)

Publication Number Publication Date
NO20023697D0 NO20023697D0 (no) 2002-08-06
NO20023697L true NO20023697L (no) 2002-10-14

Family

ID=27158210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023697A NO20023697L (no) 2000-02-21 2002-08-06 Cykliske heksapeptidderivater

Country Status (23)

Country Link
US (1) US6884774B2 (no)
EP (1) EP1259535B1 (no)
JP (1) JP3906690B2 (no)
KR (1) KR100437176B1 (no)
CN (1) CN1425026A (no)
AR (1) AR033666A1 (no)
AT (1) ATE293126T1 (no)
BR (1) BR0108792A (no)
CA (1) CA2400872C (no)
CZ (1) CZ20022844A3 (no)
DE (1) DE60110046T2 (no)
ES (1) ES2236177T3 (no)
HU (1) HUP0300066A3 (no)
IL (1) IL150904A0 (no)
MX (1) MXPA02008171A (no)
NO (1) NO20023697L (no)
NZ (1) NZ520808A (no)
OA (1) OA12180A (no)
PL (1) PL357875A1 (no)
PT (1) PT1259535E (no)
RU (1) RU2224765C1 (no)
TW (1) TWI250992B (no)
WO (1) WO2001060846A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR362001A0 (en) * 2001-03-08 2001-04-05 Fujisawa Pharmaceutical Co., Ltd. New compound
DE60220415T2 (de) * 2001-07-27 2008-02-14 Neptune Technologies & Bioressources Inc., Laval Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
AUPS044102A0 (en) * 2002-02-11 2002-03-07 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903629A0 (en) * 2003-07-14 2003-07-31 Fujisawa Pharmaceutical Co., Ltd. New compound
US20100256048A1 (en) * 2007-10-29 2010-10-07 Astellas Pharma Inc. Polypeptide compound
CN107098884A (zh) 2016-02-19 2017-08-29 中国科学院上海药物研究所 一类取代的氨基吡啶类化合物及其制备和用途
JP2021510152A (ja) * 2018-01-04 2021-04-15 北京大学深▲ヂェン▼研究生院Ｐｅｋｉｎｇ Ｕｎｉｖｅｒｓｉｔｙ Ｓｈｅｎｚｈｅｎ Ｇｒａｄｕａｔｅ Ｓｃｈｏｏｌ Ｌｓｄ１とｈｄａｃとを標的として同時に阻害する化合物及びその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
US6107458A (en) * 1994-10-07 2000-08-22 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity
JP3561917B2 (ja) * 1998-02-09 2004-09-08 藤沢薬品工業株式会社 新規化合物

Also Published As

Publication number Publication date
CZ20022844A3 (cs) 2003-01-15
CN1425026A (zh) 2003-06-18
NO20023697D0 (no) 2002-08-06
TWI250992B (en) 2006-03-11
US6884774B2 (en) 2005-04-26
IL150904A0 (en) 2003-02-12
BR0108792A (pt) 2002-12-03
RU2224765C1 (ru) 2004-02-27
US20030083238A1 (en) 2003-05-01
JP3906690B2 (ja) 2007-04-18
EP1259535A1 (en) 2002-11-27
AR033666A1 (es) 2004-01-07
MXPA02008171A (es) 2002-11-29
OA12180A (en) 2006-05-09
DE60110046T2 (de) 2005-11-17
CA2400872A1 (en) 2001-08-23
ATE293126T1 (de) 2005-04-15
DE60110046D1 (de) 2005-05-19
CA2400872C (en) 2010-11-16
EP1259535B1 (en) 2005-04-13
KR100437176B1 (ko) 2004-06-25
KR20020029792A (ko) 2002-04-19
RU2002125463A (ru) 2004-02-20
JP2003523349A (ja) 2003-08-05
HUP0300066A2 (hu) 2003-06-28
NZ520808A (en) 2004-03-26
PT1259535E (pt) 2005-06-30
WO2001060846A1 (en) 2001-08-23
PL357875A1 (en) 2004-07-26
ES2236177T3 (es) 2005-07-16
HUP0300066A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
NO20030916D0 (no) Selektive cykliske peptider
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
ATE540013T1 (de) Naphthalinderivate
DE69922494D1 (de) Zyklische n-acylamin-derivate
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
DK1571140T3 (da) Substituerede C-cyjklohexylmethylamin-derivater
AR028602A1 (es) Derivados de pirrol
AR028282A1 (es) Derivados de aminofenil pirimidona
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
FR2806446B1 (fr) Turbocompresseur
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
NO20024322L (no) Sekvens
NO990937L (no) Kunstig rev
ATE293126T1 (de) Cyclische hexapeptidderivate
DE50113112D1 (de) Schaltungsanordnung
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater
FR2806447B1 (fr) Turbocompresseur
DK1322590T3 (da) Substituerede 5-amino-1-penten-3-ol-derivater
DK1259535T3 (da) Cykliske hexapeptidderivater
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
DE50115426D1 (de) Schaltungsanordnung
AU3409501A (en) Cyclic hexapeptide derivatives

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN 6 VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0

FC2A Withdrawal, rejection or dismissal of laid open patent application